Jorge D. Brioni
About
In The Last Decade
Jorge D. Brioni
135 papers receiving 6.4k citations
Peers
Comparison fields: 5 of 117
- Molecular Biology 3.3k
- Cellular and Molecular Neuroscience 2.5k
- Cognitive Neuroscience 1.3k
- Pharmacology 981
- Physiology 911
Countries citing papers authored by Jorge D. Brioni
This map shows the geographic impact of Jorge D. Brioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge D. Brioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge D. Brioni more than expected).
Fields of papers citing papers by Jorge D. Brioni
This network shows the impact of papers produced by Jorge D. Brioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge D. Brioni. The network helps show where Jorge D. Brioni may publish in the future.
Co-authorship network of co-authors of Jorge D. Brioni
This figure shows the co-authorship network connecting the top 25 collaborators of Jorge D. Brioni. A scholar is included among the top collaborators of Jorge D. Brioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge D. Brioni. Jorge D. Brioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 32 | |
| 2 | 5 | |
| 3 | 156 | |
| 4 | 13 | |
| 5 | 158 | |
| 6 | 53 | |
| 7 | 26 | |
| 8 | 26 | |
| 9 | Neuronal nicotinic receptors : pharmacology and therapeutic opportunities | 169 |
| 10 | 25 | |
| 11 | Pharmacological treatment of Alzheimer's disease : molecular and neurobiological foundations | 24 |
| 12 | 171 | |
| 13 | 21 | |
| 14 | (S)‐3‐メチル‐5‐(1‐メチル‐2‐ピロリジニル)イソキサゾール(ART418) 認知促進および抗不安活性を持つ新しいコリン作動性リガンド II in vivoの性質 | 87 |
| 15 | 48 | |
| 16 | 18 | |
| 17 | 16 | |
| 18 | 23 | |
| 19 | 17 | |
| 20 | 124 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.